One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Stents Global Market

ステント市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Stents Global Market - Forecast to 2027


Product Code : IQ4IHC00114184
Survey : IQ4I
Publish On : July, 2021
Number of Pages : 616
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
ABBOTT LABORATORIES
B. BRAUN MELSUNGEN
BECTON, DICKINSON AND COMPANY
BIOTRONIK SE & CO. KG
BLUE SAIL MEDICAL CO. LTD.
BOSTON SCIENTIFIC CORPORATION
CARDINAL HEALTH
COOK MEDICAL INCORPORATED
MEDTRONIC PLC
TERUMO CORPORATION
LIST OF COMPANIES MENTIONED IN THE REPORT
ABBOTT LABORATORIES
ABBVIE INC. (ALLERGAN INC.)
ACANDIS GMBH
ACCURA MEDIZINTECHNIK GMBH
ALLIUM LTD.
ALVIMEDICA
ANDRATEC GMBH
ARTERIUS LIMITED
B.BRAUN MELSUNGEN AG
BALT EXTRUSION
BALTON SP. Z O.O.
BECTON, DICKINSON AND COMPANY
BENTLEY INNOMED GMBH
BESS AG
BIOTEQUE CORPORATION
BIOTRONIK SE & CO. KG
BLUE SAIL MEDICAL CO. LTD (BIOSENSORS INTERNATIONAL PTE LTD)
BOSTON SCIENTIFIC CORPORATION
CARDINAL HEALTH INC.
CELONOVA BIOSCIENCES, INC.
CONMED CORPORATION
COOK MEDICAL LLC
DISA VASCULAR (PTY) LTD. (DISA MEDINOTEC)
DISPOMEDICA GMBH
ELIXIR MEDICAL CORPORATION
ELLA - CS, S.R.O
ENDOCOR GMBH
ENDOGI MEDICAL
EUCATECH AG
EUROCOR TECH GMBH
GENOSS CO., LTD.
GLAUKOS CORPORATION
HEXACATH INTERNATIONAL
HOBBS MEDICAL INC.
HYDRUSTENT SA
INSPIREMD
IVANTIS INC.
IVASCULAR S.L.U.
KYOTO MEDICAL PLANNING CO. LTD.
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
M.I.TECH CO., LTD.
MED PRO MEDICAL B.V.
MEDAS INC.
MEDICUT STENT TECHNOLOGY GMBH
MEDINOL LTD.
MEDTRONIC PLC
MERIL LIFE SCIENCES PVT. LTD.
MERIT MEDICAL SYSTEMS INC. (BRIGHTWATER MEDICAL)
MERLIN MD PTE. LTD.
MICELL TECHNOLOGIES, INC.
MICRO MEDICAL SOLUTIONS
MICRO SCIENCE MEDICAL AG
MICROPORT SCIENTIFIC CORPORATION
MICRO-TECH (NANJING) CO., LTD.
NANOSTENT
NUMED INC.
OLYMPUS CORPORATION
OPTIMED MEDIZINISCHE INSTRUMENTE GMBH
OPTO CIRCUITS (INDIA) LIMITED
ORBUSNEICH MEDICAL COMPANY LIMITED
PALEX MEDICAL SA
PHENOX GMBH
PLUS MEDICA NORDIC AB
PNN MEDICAL A/S
POSEIDON MEDICAL INC.
Q3 MEDICAL DEVICES LTD.
RELISYS MEDICAL DEVICES LIMITED
REVA MEDICAL INC.
RONTIS AG
SAHAJANAND MEDICAL TECHNOLOGIES PVT. LTD.
SCITECH PRODUTOS MÉDICOS SA.
SILK ROAD MEDICAL INC.
STENING SRL
STRYKER CORPORATION
SVELTE MEDICAL SYSTEMS INC.
SYNLAS GMBH & CO.KG
TAEWOONG MEDICAL CO., LTD.
TERUMO CORPORATION
THORACENT, INC.
TRANSLUMINA THERAPEUTICS
USM HEALTHCARE MEDICAL DEVICES FACTORY JSC
VYGON SA (PEROUSE MEDICAL)
W. L. GORE & ASSOCIATES, INC.
WELLINQ HOLDING B.V.
ZHEJIANG CHUANGXIANG MEDICAL TECHNOLOGY CO., LTD.

[Report Description]

Stents are the miniaturized, flexible or expandable tube like structures used to widen and establish patency of the clogged vascular or non-vascular tubular structures and to ensure steady flow of body fluids through them. Compared to the traditional highly invasive surgical repair procedures, the current minimally invasive transcatheter therapeutic procedures with highly efficient, technologically advanced stent products assure patients and healthcare providers with improved efficiency, effectiveness and quicker restoration of the narrowed vessel’s or duct’s natural function. Increased utilization of the various stent products for the numerous and varied types of vascular and non-vascular obstructive conditions and cerebral aneurysm among the patients, elevating inclination of the value centric global patient pool towards the minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to rapidly mitigate the clinical manifestations associated with blocked vascular and non-vascular hollow organs or weakened vascular bed, reduce hospitalization duration and ease and improve the patient’s condition quickly through efficient and safer interventional products are fuelling the stents global market.
As estimated by IQ4I Research, the stents global market is expected to reach $13,522.8 million by 2027 growing at a mid single digit CAGR from 2020 to 2027, due to increasing prevalence of various kinds of stenotic diseases and cerebral aneurysm across the globe, increasing demand for highly efficient, minimally invasive therapeutic products from the value centric patient population, the trend of coronary stent price slashing and increasing competitiveness of the domestic players in some of the major APAC countries, favorable reimbursement scenario in developed nations, emergence of technologically advanced stent products, persistently escalating geriatric population and the feasibility of even drug eluting stents (DES) in them and the numerous acquisitions and distribution agreements among the stent companies, developing healthcare infrastructural facilities and increasing demand for better healthcare services in the emerging markets. The stents market is segmented by product, material, application, end-users and geography.
Based on the product, the stents global market is segmented into bare metal stents, drug eluting stents (DES), bioresorbable stents and other stents consisting of covered stents and the non-drug eluting polymeric stents. Among these products, the drug eluting stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to increasing popularity and adoption of the highly efficient DES across the globe and the constant technological and engineering improvements in these stent products. Bioresorbable stents segment is the fastest emerging segment and is expected of growing at a low teen CAGR during the forecasted period due to increasing research and development activities for the development of highly efficient and safer biodegradable stents that will gradually disappear after improving the patency of the narrowed vessel or duct.
Based on the materials used, the stents global market is segmented into metal alloy based stents and polymer based stents. The metal alloy based stents is further categorized into cobalt-chrome alloy stents, nitinol or nickel-titanium alloy stents, platinum-chromium alloy stents, stainless steel stents and other metallic biomaterial stents like those made up of magnesium, iron and others. The polymer based stents includes stents made up of durable or biostable polymers and biodegradable polymers. In the overall stents market based on materials, the metal alloy based stents segment accounted for the largest share in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to the increasing utilization of various metallic materials in the production of bare metal stents (BMS), drug eluting stents (DES), covered stents and even the bioresorbable stents and the exhibition of the most desirable and advantageous stent characteristics like high tensile or mechanical strength, elasticity, rigidity and radiopacity by the metallic biomaterials. Among metal alloy based stents, cobalt-chrome alloy stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 while nitinol alloy stents segment is the fastest emerging segment and is expected of growing at a mid single digit CAGR from 2020 to 2027. Polymer based stents segment is the fastest emerging segment growing at a high single digit CAGR from 2020 to 2027 due to the escalating utilization of polymers in the manufacturing of DES, covered stents, polymeric non drug eluting stents and the polymeric bioresorbable stents and the manifestation of stent advantageous characteristics like flexibility, elasticity and the controlled drug elution kinetics by the polymers. Among the different kinds of polymer based stents, durable polymer based stents segment accounted for the largest revenue in 2020 and is expected to grow at a high single digit CAGR during the forecasted period while biodegradable polymer based stents segment is the fastest emerging segment growing at a low teen CAGR from 2020 to 2027.
Based on the application, stents global market is broadly classified as vascular and non-vascular stents. Among these, the vascular stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to the persistently elevating prevalence of vascular stenotic conditions and cerebral aneurysm across the globe that is in need of various rapid, efficient, technologically advanced and minimally traumatizing therapeutic interventions like stenting. The vascular stents are further segmented into coronary artery stents, peripheral artery stents, neurovascular stents and others consisting of venous stents, vertebral artery stents and pulmonary artery stents. Among these, the coronary artery stent segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 while neurovascular stents segment is the fastest emerging segment and is expected of growing at a high single digit CAGR from 2020 to 2027. Neurovascular stents can be further classified into carotid artery stents, intracranial stents and flow diverter stents for treating cerebral aneurysms. Among the various neurovascular stents, carotid artery stents accounted for the largest revenue in 2020 and is expected to grow at double digit CAGR during 2020 to 2027. Based on the application type, non-vascular stents are segmented into gastrointestinal stents, urinary tract stents or urological stents, airway or tracheobronchial stents or pulmonary stents and others consisting of ophthalmic stents. Among these, the gastrointestinal stents (GI) segment accounted for the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027. GI stents are further segmented as pancreatic and biliary stents, colonic or colorectal stents, esophageal stents and duodenal stents. Among these, the Pancreatic & Biliary Stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027.
Based on the end-users, the stents global market is divided into Hospitals; Ambulatory surgery centers (ASCs) and others consisting of Freestanding or mobile Catheterization Labs and Research Institutes. Among the various end-users, Hospitals segment accounted for the largest revenue in 2020 and is expected to grow at a low single digit CAGR during the period 2020 to 2027 due to increased utilization of various types of stent products for the stenting procedures performed in the hospital associated in-patient or out-patient settings. Ambulatory Surgery Centers (ASCs) segment is the fastest emerging segment and is expected of growing at a mid single digit CAGR from 2020 to 2027.
Based on the region, the stents global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Turkey, Rest of Latin America and Middle East & Africa). The major share of the stents global market is occupied by Asia-Pacific in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 mainly due to the persistently elevating prevalence of vascular and non-vascular stenotic conditions in the region, increasing affordability and accessibility of the major stent products like coronary stents among the patients of some of the major countries in the region attributed to government imposed price slashing measures for these life-saving devices, elevating geriatric population impaired with various kinds of vascular or non-vascular obstructive diseases, increasing patient awareness and demand for better, quick minimally invasive, efficient therapeutic procedures with advanced therapeutic products, growing economies of the region, persistently developing healthcare infrastructural facilities in the region, increasing healthcare expenditures and medical tourism aspects of the region. Rest of World (ROW) is the fastest emerging region and is expected of growing at a high single digit CAGR during the forecasted period. The rapid market growth rate of stents market in this region is due to escalating prevalence of vasculature and duct system associated obstructive conditions in the region, increasing geriatric population loaded with various kinds of stenotic conditions, increasing patient awareness and demand for better, quick minimally invasive therapeutic procedures and efficient therapeutic products, growing economies of the region, increasing per capita expenditure on healthcare needs and medical tourism prospects of the region.
The stents global market is consolidated with few companies dominating and occupying major share of the market. Some of the leading players in stents market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Cook Medical LLC (U.S.), Cardinal Health Inc. (U.S.), Becton, Dickinson and company (U.S.), B. Braun Melsungen AG (Germany), Biotronik SE & Co.KG (Germany), Blue Sail Medical Co. Ltd (Biosensors International Pte Ltd) (China) and others.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of North America
• Europe
o Germany
o France
o Italy
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Rest of APAC
• Rest of the World (RoW)
o Brazil
o Turkey
o Rest of LATAM and Middle East and Africa


1 EXECUTIVE SUMMARY 23
2 INTRODUCTION 32
2.1 KEY TAKEAWAYS 32
2.2 SCOPE OF THE REPORT 33
2.3 REPORT DESCRIPTION 33
2.4 MARKETS COVERED 38
2.5 STAKEHOLDERS 40
2.6 RESEARCH METHODOLOGY 41
2.6.1 MARKET SIZE ESTIMATION 43
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 46
2.6.3 SECONDARY SOURCES 47
2.6.4 PRIMARY SOURCES 48
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 48
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 49
2.6.7 ASSUMPTIONS 49
3 MARKET ANALYSIS 52
3.1 INTRODUCTION 52
3.2 MARKET SEGMENTATION 54
3.3 FACTORS INFLUENCING MARKET 56
3.3.1 DRIVERS AND OPPORTUNITIES 57
3.3.1.1 Escalating prevalence of vascular and non-vascular stenotic diseases and cerebral aneurysm 57
3.3.1.2 Elevating inclination towards minimally invasive therapeutic approaches 59
3.3.1.3 The trend of coronary stent price slashing and increasing competitiveness of domestic players in apac countries 61
3.3.1.4 Emergence of technologically advanced products 63
3.3.1.5 Escalating geriatric population and feasibility of drug eluting stents in them 65
3.3.1.6 Acquisitions and distribution agreements to open an array of opportunities for the market to flourish 66
3.3.1.7 Favourable reimbursement policies escalating stent technology diffusion in developed nations 67
3.3.2 RESTRAINTS AND THREATS 68
3.3.2.1 Stringent regulatory bodies guiding stent manufacturers 68
3.3.2.2 The threat of commercialized stent recalls 71
3.3.2.3 Lack of skilled, experienced and trained healthcare professionals 72
3.3.2.4 Adverse effects of stents 74
3.3.2.5 Concerns over irrational stenting and under-performance of stents in complex stenotic diseases or lesions 75
3.4 REGULATORY AFFAIRS 77
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 77
3.4.1.1 ISO 9001: 2015 quality management system 77
3.4.1.2 ISO 14644-1 clean room standards 77
3.4.1.3 ISO 13485 medical devices 78
3.4.1.4 ISO 10993 biological evaluation of medical devices 78
3.4.1.5 ISO 14971: risk management of medical devices 79
3.4.1.6 ISO 25539-2:2020 cardiovascular implants — endovascular devices — part 2: vascular stents 79
3.4.1.7 ISO 25539-1 79
3.4.1.8 ISO 12417-1 80
3.4.1.9 ISO/TS 17137 80
3.4.1.10 ISO 17327-1 80
3.4.1.11 IEC 60601-1 medical electrical equipment standard 80
3.4.2 ASTM INTERNATIONAL STANDARDS 80
3.4.3 U.S. 81
3.4.4 CANADA 84
3.4.5 EUROPE 84
3.4.6 JAPAN 85
3.4.7 CHINA 86
3.4.8 INDIA 88
3.5 TECHNOLOGICAL ADVANCEMENTS 90
3.5.1 INTRODUCTION 90
3.5.2 SMART STENTS 90
3.5.3 3D-PRINTED STENTS 91
3.5.4 INDIRECT 4D PRINTING AND MICROSTENTS 91
3.5.5 NANOCOATED NON-DRUG ELUTING STENT AND ULTRASHORT DAPT 92
3.5.6 BIOENGINEERED STENTS 92
3.5.7 GENE ELUTING STENTS (GES) 92
3.5.8 BIORESORBABLE STENTS 93
3.6 STENTS COATING MATERIALS 94
3.6.1 INORGANIC COATING MATERIALS 95
3.6.2 ORGANIC COATING MATERIALS 96
3.6.3 BIOLOGICAL COATING MATERIALS OR BIOCOATINGS 98
3.6.4 CHEMOTHERAPUTICS OR DRUGS 101
3.7 PORTER’S FIVE FORCE ANALYSIS 104
3.7.1 THREAT OF NEW ENTRANTS 105
3.7.2 THREAT OF SUBSTITUTES 107
3.7.3 BARGAINING POWER OF SUPPLIERS 108
3.7.4 BARGAINING POWER OF BUYERS 109
3.7.5 COMPETITIVE RIVALRY 109
3.8 SUPPLY CHAIN ANALYSIS 111
3.9 REIMBURSEMENT SCENARIO 119
3.10 PATENT TRENDS 123
3.11 REGULATORY APPROVAL ANALYSIS 125
3.12 CLINICAL TRIALS 137
3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 139
3.13.1 STENTS GLOBAL MARKET SHARE ANALYSIS 139
3.13.2 CORONARY STENTS GLOBAL MARKET SHARE ANALYSIS 142
3.13.3 PERIPHERAL STENTS GLOBAL MARKET SHARE ANALYSIS 146
3.13.4 NEUROVASCULAR STENTS GLOBAL MARKET SHARE ANALYSIS 149
3.13.4.1 Flow diverters global market share analysis 152
3.13.4.2 Intracranial stent global market share analysis 154
3.13.4.3 Carotid stent global market share analysis 156
3.13.5 GASTROINTESTINAL STENTS GLOBAL MARKET SHARE ANALYSIS 158
3.13.6 DRUG ELUTING STENTS GLOBAL MARKET SHARE ANALYSIS 161
3.14 STENTS - NUMBER OF PROCEDURES BY REGION 164
3.14.1 CORONARY STENT IMPLANTATION PROCEDURAL VOLUME BY REGION 164
3.14.2 PERIPHERAL STENT IMPLANTATION PROCEDURAL VOLUME BY REGION 166
3.15 STENTS COMPANY COMPARISON TABLE BY REVENUE, PRODUCT, PRODUCT TYPE, APPLICATION, MATERIAL AND INDICATION 168
4 STENTS GLOBAL MARKET, BY PRODUCT 195
4.1 INTRODUCTION 195
4.2 BARE METAL STENTS 199
4.3 DRUG ELUTING STENTS 203
4.4 BIORESORBABLE STENTS 208
4.5 OTHER STENTS 215
5 STENTS GLOBAL MARKET, BY MATERIAL 219
5.1 INTRODUCTION 219
5.2 METAL ALLOY BASED STENTS 223
5.2.1 COBALT CHROME ALLOY STENTS 228
5.2.2 NITINOL ALLOY STENTS 231
5.2.3 STAINLESS STEEL STENTS 234
5.2.4 PLATINUM ALLOY STENTS 237
5.2.5 OTHER METAL ALLOY STENTS 240
5.3 POLYMER BASED STENTS 243
5.3.1 DURABLE POLYMER STENTS 248
5.3.2 BIODEGRADABLE POLYMER STENTS 253
6 STENTS GLOBAL MARKET, BY APPLICATION 256
6.1 INTRODUCTION 256
6.2 VASCULAR STENTS 259
6.2.1 CORONARY ARTERY STENTS 264
6.2.2 PERIPHERAL ARTERY STENTS 268
6.2.3 NEUROVASCULAR STENTS 273
6.2.3.1 Carotid artery stents 277
6.2.3.2 Intracranial stents 280
6.2.3.3 Flow diverter stents 284
6.2.4 RENAL ARTERY STENTS 286
6.2.5 OTHER VASCULAR STENTS 289
6.3 NON-VASCULAR STENTS 294
6.3.1 GASTROINTESTINAL STENTS 300
6.3.1.1 Pancreatic & biliary stents 305
6.3.1.2 Colorectal stents 309
6.3.1.3 Esophageal stents 312
6.3.1.4 Duodenal stents 316
6.3.2 UROLOGICAL STENTS 319
6.3.3 AIRWAY STENTS 323
6.3.4 OTHER NON-VASCULAR STENTS 326
7 STENTS GLOBAL MARKET, BY END-USERS 329
7.1 INTRODUCTION 329
7.2 HOSPITALS 332
7.3 AMBULATORY SURGERY CENTERS 336
7.4 OTHER END-USERS 339
8 REGIONAL ANALYSIS 343
8.1 INTRODUCTION 343
8.2 NORTH AMERICA 348
8.2.1 U.S. 368
8.2.2 REST OF NORTH AMERICA 376
8.3 EUROPE 386
8.3.1 GERMANY 406
8.3.2 FRANCE 413
8.3.3 ITALY 419
8.3.4 REST OF EUROPE 425
8.4 APAC 434
8.4.1 CHINA 454
8.4.2 JAPAN 462
8.4.3 INDIA 469
8.4.4 REST OF APAC 478
8.5 REST OF THE WORLD 486
8.5.1 BRAZIL 506
8.5.2 TURKEY 512
8.5.3 REST OF LATAM AND MEA 518
9 COMPETITIVE LANDSCAPE 526
9.1 INTRODUCTION 526
9.2 PRODUCT APPROVAL 528
9.3 CLINICAL STUDIES/INVESTIGATIONS 531
9.4 PRODUCT LAUNCH 534
9.5 ACQUISITION 536
9.6 OTHER DEVELOPMENTS 536
10 MAJOR COMPANIES 539
10.1 ABBOTT LABORATORIES 539
10.1.1 OVERVIEW 539
10.1.2 FINANCIALS 540
10.1.3 PRODUCT PORTFOLIO 544
10.1.4 KEY DEVELOPMENTS 545
10.1.5 BUSINESS STRATEGY 546
10.1.6 SWOT ANALYSIS 547
10.2 B. BRAUN MELSUNGEN AG 548
10.2.1 OVERVIEW 548
10.2.2 FINANCIALS 549
10.2.3 PRODUCT PORTFOLIO 552
10.2.4 KEY DEVELOPMENTS 552
10.2.5 BUSINESS STRATEGY 553
10.2.6 SWOT ANALYSIS 554
10.3 BECTON, DICKINSON AND COMPANY 555
10.3.1 OVERVIEW 555
10.3.2 FINANCIALS 556
10.3.3 PRODUCT PORTFOLIO 560
10.3.4 KEY DEVELOPMENTS 561
10.3.5 BUSINESS STRATEGY 561
10.3.6 SWOT ANALYSIS 562
10.4 BIOTRONIK SE & CO. KG 563
10.4.1 OVERVIEW 563
10.4.2 FINANCIALS 563
10.4.3 PRODUCT PORTFOLIO 564
10.4.4 KEY DEVELOPMENTS 565
10.4.5 BUSINESS STRATEGY 567
10.4.6 SWOT ANALYSIS 568
10.5 BLUE SAIL MEDICAL CO. LTD (BIOSENSORS INTERNATIONAL PTE LTD.) 569
10.5.1 OVERVIEW 569
10.5.2 FINANCIALS 569
10.5.3 PRODUCT PORTFOLIO 570
10.5.4 KEY DEVELOPMENTS 570
10.5.5 BUSINESS STRATEGY 571
10.5.6 SWOT ANALYSIS 572
10.6 BOSTON SCIENTIFIC CORPORATION 573
10.6.1 OVERVIEW 573
10.6.2 FINANCIALS 574
10.6.3 PRODUCT PORTFOLIO 579
10.6.4 KEY DEVELOPMENTS 581
10.6.5 BUSINESS STRATEGY 582
10.6.6 SWOT ANALYSIS 583
10.7 CARDINAL HEALTH INC. 584
10.7.1 OVERVIEW 584
10.7.2 FINANCIALS 585
10.7.3 PRODUCT PORTFOLIO 589
10.7.4 KEY DEVELOPMENTS 589
10.7.5 BUSINESS STRATEGY 590
10.7.6 SWOT ANALYSIS 591
10.8 COOK MEDICAL LLC 592
10.8.1 OVERVIEW 592
10.8.2 FINANCIALS 592
10.8.3 PRODUCT PORTFOLIO 593
10.8.4 KEY DEVELOPMENTS 595
10.8.5 BUSINESS STRATEGY 596
10.8.6 SWOT ANALYSIS 597
10.9 MEDTRONIC PLC 598
10.9.1 OVERVIEW 598
10.9.2 FINANCIALS 599
10.9.3 PRODUCT PORTFOLIO 604
10.9.4 KEY DEVELOPMENTS 605
10.9.5 BUSINESS STRATEGY 606
10.9.6 SWOT ANALYSIS 607
10.10 TERUMO CORPORATION 608
10.10.1 OVERVIEW 608
10.10.2 FINANCIALS 609
10.10.3 PRODUCT PORTFOLIO 612
10.10.4 KEY DEVELOPMENTS 612
10.10.5 BUSINESS STRATEGY 614
10.10.6 SWOT ANALYSIS 615

LIST OF FIGURES
FIGURE 1 STENTS GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN) 31
FIGURE 2 RESEARCH METHODOLOGY: STENTS GLOBAL MARKET 43
FIGURE 3 STENTS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 44
FIGURE 4 STENTS GLOBAL MARKET: FORECASTING MODEL 45
FIGURE 5 STENTS GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION 46
FIGURE 6 STENTS GLOBAL MARKET SEGMENTATION 55
FIGURE 7 MARKET DYNAMICS 56
FIGURE 8 STENTS GLOBAL MARKET: PORTER’S ANALYSIS 104
FIGURE 9 STENTS: SUPPLY CHAIN ANALYSIS 111
FIGURE 10 STENTS GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2016–2021) 124
FIGURE 11 STENTS CLINICAL TRIAL ANALYSIS 138
FIGURE 12 STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 139
FIGURE 13 CORONARY STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 142
FIGURE 14 PERIPHERAL STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 146
FIGURE 15 NEUROVASCULAR STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 149
FIGURE 16 FLOW DIVERTERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 152
FIGURE 17 INTRACRANIAL STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 154
FIGURE 18 CAROTID STENT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 156
FIGURE 19 GASTROINTESTINAL STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 158
FIGURE 20 DRUG ELUTING STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%) 161
FIGURE 21 STENTS GLOBAL MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%) 198
FIGURE 22 STENTS GLOBAL MARKET SHARE, BY MATERIAL (2020 V/S 2027) (%) 222
FIGURE 23 METAL ALLOY BASED STENTS GLOBAL MARKET SHARE, BY MATERIAL TYPE (2020 V/S 2027) (%) 226
FIGURE 24 POLYMER BASED STENTS GLOBAL MARKET SHARE, BY MATERIAL TYPE (2020 V/S 2027) (%) 246
FIGURE 25 DURABLE POLYMER BASED STENTS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%) 252
FIGURE 26 STENTS GLOBAL MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%) 258
FIGURE 27 VASCULAR STENTS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2020 V/S 2027) (%) 262
FIGURE 28 NEUROVASCULAR STENTS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2020 V/S 2027) (%) 275
FIGURE 29 INTRACRANIAL STENTS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%) 283
FIGURE 30 NON-VASCULAR STENTS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2020 V/S 2027) (%) 297
FIGURE 31 NON-VASCULAR STENTS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%) 299
FIGURE 32 GASTROINTESTINAL STENTS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2020 V/S 2027) (%) 303
FIGURE 33 ESOPHAGEAL STENTS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%) 315
FIGURE 34 STENTS GLOBAL MARKET SHARE, BY END-USERS (2020 V/S 2027) (%) 331
FIGURE 35 STENTS GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN), CAGR (%) 346
FIGURE 36 STENTS GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2020) (%) 347
FIGURE 37 NORTH AMERICA STENTS MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%) 362
FIGURE 38 NORTH AMERICA STENTS MARKET SHARE, BY MATERIAL AND METAL ALLOY & POLYMER STENTS BY MATERIAL TYPE (2020 V/S 2027) (%) 363
FIGURE 39 NORTH AMERICA STENTS MARKET SHARE, BY APPLICATION (2020 V/S 2027) % AND VASCULAR & NON-VASCULAR STENTS
BY APPLICATION TYPE (2020) (%) 364
FIGURE 40 NORTH AMERICA STENTS MARKET SHARE, BY END-USERS (2020 V/S 2027) (%) 365
FIGURE 41 NORTH AMERICA STENTS MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%) 367
FIGURE 42 U.S. STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 374
FIGURE 43 U.S. VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 375
FIGURE 44 REST OF NORTH AMERICA STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 384
FIGURE 45 REST OF NORTH AMERICA VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 385
FIGURE 46 EUROPE STENTS MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%) 400
FIGURE 47 EUROPE STENTS MARKET SHARE, BY MATERIAL AND METAL ALLOY & POLYMER STENTS BY MATERIAL TYPE (2020 V/S 2027) (%) 401
FIGURE 48 EUROPE STENTS MARKET SHARE, BY APPLICATION (2020 V/S 2027) % AND VASCULAR & NON-VASCULAR STENTS BY APPLICATION TYPE (2020) (%) 402
FIGURE 49 EUROPE STENTS MARKET SHARE, BY END-USERS (2020 V/S 2027) (%) 403
FIGURE 50 EUROPE STENTS MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%) 405
FIGURE 51 GERMANY STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 411
FIGURE 52 GERMANY VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 412
FIGURE 53 FRANCE STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 417
FIGURE 54 FRANCE VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 418
FIGURE 55 ITALY STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 423
FIGURE 56 ITALY VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 424
FIGURE 57 REST OF EUROPE STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 432
FIGURE 58 REST OF EUROPE VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 433
FIGURE 59 APAC STENTS MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%) 448
FIGURE 60 APAC STENTS MARKET SHARE, BY MATERIAL AND METAL ALLOY & POLYMER STENTS BY MATERIAL TYPE (2020 V/S 2027) (%) 449
FIGURE 61 APAC STENTS MARKET SHARE, BY APPLICATION (2020 V/S 2027) % AND VASCULAR & NON-VASCULAR STENTS BY APPLICATION TYPE (2020) (%) 450
FIGURE 62 APAC STENTS MARKET SHARE, BY END-USERS (2020 V/S 2027) (%) 451
FIGURE 63 APAC STENTS MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%) 453
FIGURE 64 CHINA STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 460
FIGURE 65 CHINA VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 461
FIGURE 66 JAPAN STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 467
FIGURE 67 JAPAN VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 468
FIGURE 68 INDIA STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 476
FIGURE 69 INDIA VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 477
FIGURE 70 REST OF APAC STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 484
FIGURE 71 REST OF APAC VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 485
FIGURE 72 ROW STENTS MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%) 500
FIGURE 73 ROW STENTS MARKET SHARE, BY MATERIAL AND METAL ALLOY & POLYMER STENTS BY MATERIAL TYPE (2020 V/S 2027) (%) 501
FIGURE 74 ROW STENTS MARKET SHARE, BY APPLICATION (2020 V/S 2027) % AND VASCULAR & NON-VASCULAR STENTS BY APPLICATION TYPE (2020) (%) 502
FIGURE 75 ROW STENTS MARKET SHARE, BY END-USERS (2020 V/S 2027) (%) 503
FIGURE 76 ROW STENTS MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%) 505
FIGURE 77 BRAZIL STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 510
FIGURE 78 BRAZIL VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 511
FIGURE 79 TURKEY STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 516
FIGURE 80 TURKEY VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 517
FIGURE 81 REST OF LATAM AND MEA STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN) 524
FIGURE 82 REST OF LATAM AND MEA VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN) 525
FIGURE 83 KEY DEVELOPMENTS (2019 –2020) 526
FIGURE 84 SWOT: ABBOTT LABORATORIES 547
FIGURE 85 SWOT: B. BRAUN MELSUNGEN 554
FIGURE 86 SWOT: BECTON, DICKINSON AND COMPANY 562
FIGURE 87 SWOT: BIOTRONIK SE & CO. KG 568
FIGURE 88 SWOT: BLUE SAIL MEDICAL CO. LTD. 572
FIGURE 89 SWOT: BOSTON SCIENTIFIC CORPORATION 583
FIGURE 90 SWOT: CARDINAL HEALTH 591
FIGURE 91 SWOT: COOK MEDICAL INCORPORATED 597
FIGURE 92 SWOT: MEDTRONIC PLC. 607
FIGURE 93 SWOT: TERUMO CORPORATION 615

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+